de Arriba de la Fuente, F.; Gironella Mesa, M.; Hernández GarcÃa, M.T.; Soler Campos, J.A.; Herráez RodrÃguez, S.; Moreno Belmonte, M.J.; Regueiro López, T.; González-Pardo, M.; Casanova Espinosa, M.; on behalf of the CARINAE Study Investigators.
Unravelling Transplant-Ineligible Newly Diagnosed Multiple Myeloma Treatment in Real-World Practice in Spain: The CARINAE Study. Pharmaceuticals 2024, 17, 1272.
https://doi.org/10.3390/ph17101272
AMA Style
de Arriba de la Fuente F, Gironella Mesa M, Hernández GarcÃa MT, Soler Campos JA, Herráez RodrÃguez S, Moreno Belmonte MJ, Regueiro López T, González-Pardo M, Casanova Espinosa M, on behalf of the CARINAE Study Investigators.
Unravelling Transplant-Ineligible Newly Diagnosed Multiple Myeloma Treatment in Real-World Practice in Spain: The CARINAE Study. Pharmaceuticals. 2024; 17(10):1272.
https://doi.org/10.3390/ph17101272
Chicago/Turabian Style
de Arriba de la Fuente, Felipe, Mercedes Gironella Mesa, Miguel Teodoro Hernández GarcÃa, Juan Alonso Soler Campos, Susana Herráez RodrÃguez, MarÃa José Moreno Belmonte, Teresa Regueiro López, Miriam González-Pardo, MarÃa Casanova Espinosa, and on behalf of the CARINAE Study Investigators.
2024. "Unravelling Transplant-Ineligible Newly Diagnosed Multiple Myeloma Treatment in Real-World Practice in Spain: The CARINAE Study" Pharmaceuticals 17, no. 10: 1272.
https://doi.org/10.3390/ph17101272
APA Style
de Arriba de la Fuente, F., Gironella Mesa, M., Hernández GarcÃa, M. T., Soler Campos, J. A., Herráez RodrÃguez, S., Moreno Belmonte, M. J., Regueiro López, T., González-Pardo, M., Casanova Espinosa, M., & on behalf of the CARINAE Study Investigators.
(2024). Unravelling Transplant-Ineligible Newly Diagnosed Multiple Myeloma Treatment in Real-World Practice in Spain: The CARINAE Study. Pharmaceuticals, 17(10), 1272.
https://doi.org/10.3390/ph17101272
